| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT01575548 | Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No… | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT03850964 | Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and… | Hereditary Hemorrhagic Telangiectasia | Active, Not Recruiting |
| NCT02180867 | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in… | Alveolar Soft Part Sarcoma | Active, Not Recruiting |
| NCT05432791 | Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma… | Locally Advanced Uterine Corpus Leiomyosarcoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT01217931 | Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial | Kidney Cancer | Active, Not Recruiting |
| NCT01841736 | Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors | Foregut Neuroendocrine Tumor | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06239272 | NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin… | Adipocytic Neoplasm | Recruiting |
| NCT05180695 | HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue… | Advanced Soft-tissue Sarcoma | Active, Not Recruiting |
| NCT01684397 | Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated… | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| NCT02331498 | Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma… | Glioblastoma Multiforme | Active, Not Recruiting |
| Phase 1 | |||
| NCT07444619 | A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab… | Soft Tissue Sarcomas | Not Yet Recruiting |
| NCT01552356 | Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors | Solid Neoplasm | Active, Not Recruiting |
| Not specified | |||
| NCT04199026 | Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients… | Metastatic Sarcoma | Recruiting |